Therefore, predicted expressions of the CCNB1, CDC42, MAPK7 and CD44 oncogenes exhibited significant roles in the cell cycle, and thus are potential prognostic biomarkers in GBM. This evidence concerns the gene MAPK7 and glioblastoma.